Feature | August 27, 2012

The company launches software in Portuguese and invests in online course of the Brazilian Society of Radiotherapy to increase the accessibility and quality of radiation therapy treatment in Brazil

Stock image

August 27, 2012 — Varian Medical Systems, a manufacturer of technology for the treatment of cancer with radiotherapy and radiosurgery, has launched Portuguese versions of its software systems for planning and managing radiotherapy treatments. Varian personnel worked with Brazilian cancer treatment specialists to translate its software products into Portuguese and also to adapt them so that they facilitate Brazilian treatment practices, in order to support the safe and effective use of radiotherapy in the country.

"We felt this was a very important step to take, in order to support Brazilian professionals who need to use radiotherapy technology but may not speak fluent English," said Kolleen Kennedy, president of Varian's Oncology Systems business.   

Radiotherapy is indicated for more than 60 percent of all cancer cases, including the most prevalent in the Brazilian population: prostate and lung cancer among men, and breast and cervical cancer among women. Modern radiotherapy requires development of a complex treatment plan, using software programs such as Varian's Eclipse (for treatment planning) and Aria (for managing all aspects of treatment).

Varian is also expanding its investment in radiotherapy training for Brazilian specialists. The company signed an agreement with Capes (Federal Agency of Support and Evaluation of Postgraduate Education) for investments in the Science Without Borders program, an initiative of the federal government to promote the consolidation, expansion and internationalization of science, technology and innovation through the exchange and the international mobility of students and researchers. In addition, through the Varian Foundation, it will provide financial resources for implementing an ongoing distance education program being created by the Brazilian Society of Radiotherapy (SBRT) to update professionals around the country. The SBRT will choose the faculty for this distance learning series. Classes will be transmitted through a virtual platform hosted on the site of SBRT.

"The goal of this online course is to bring knowledge of new technologies to professionals in areas that are remote from major centers, enabling them to make better treatment decisions in accordance with current technological capabilities. This will improve the level of radiotherapy expertise in the country and will have direct impact on patient access to more advanced treatments in these regions, effectively delivered by professionals with the proper skill levels," says Dr. Robson Ferrigno, president of SBRT.

Varian in Brazil

Varian has had a long and productive relationship with Brazil's cancer treatment community, having supplied the country's first linear accelerator to Hospital Oswaldo Cruz in 1971. 

Currently, Varian technology is deployed at many of Brazil's preeminent cancer treatment institutions including the National Cancer Institute (INCA) in Rio de Janeiro, Hospital Israelita Albert Einstein, Hospital AC Camargo and Hospital Sirio Libanes, in Sao Paulo.

The company currently has an office in Sao Paulo, with nearly 60 Brazilian employees.

For more information, visit www.varian.com

 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now